New Drug Ad Guidelines Unlikely to Satisfy. Theresa Agovino.
by Agovino, Theresa; ProQuest Information and Learning Company.
Series: SIRS Enduring Issues 2006Article 74Business. Publisher: Concord Monitor, 2005ISSN: 1522-3191;.Subject(s): Advertising -- Drugs | Deceptive advertising | Pharmaceutical industry | Prescription drugsDDC classification: 050 Summary: "The pharmaceutical industry unveiled new guidelines Tuesday [Aug. 2, 2005] for the consumer marketing of medicines, including pledges to educate doctors before beginning consumer campaigns and more clearly outline the risks involved in taking prescription drugs." (CONCORD MONITOR) The article reveals that the industry promises to "put off consumer advertising while doctors learn about drugs," citing the Vioxx incident where "ads pushed many patients who really didn't require the pricey drug to take it, potentially exposing them to dangerous side effects."| Item type | Current location | Call number | Status | Date due |
|---|---|---|---|---|
Books
|
High School - old - to delete | REF SIRS 2006 Business Article 74 (Browse shelf) | Available |
Articles Contained in SIRS Enduring Issues 2006.
Originally Published: New Drug Ad Guidelines Unlikely to Satisfy, Aug. 2, 2005; pp. n.p..
"The pharmaceutical industry unveiled new guidelines Tuesday [Aug. 2, 2005] for the consumer marketing of medicines, including pledges to educate doctors before beginning consumer campaigns and more clearly outline the risks involved in taking prescription drugs." (CONCORD MONITOR) The article reveals that the industry promises to "put off consumer advertising while doctors learn about drugs," citing the Vioxx incident where "ads pushed many patients who really didn't require the pricey drug to take it, potentially exposing them to dangerous side effects."
Records created from non-MARC resource.
There are no comments for this item.